Loading
Orthopedic Infections and Treatments / Bone and Joint Diseases · Journal article
Clinical Infectious Diseases · July 30, 2026
A consensus or society position rather than new primary data.
This is a critical commentary on current guidelines for diabetic foot osteomyelitis that recommend tailoring antimicrobial therapy based on surgical resection margins. The authors argue that while conceptually attractive, this approach relies on an ill-defined and inconsistently measured construct, with limited prospective validation and discordance across surgical, histopathological, and microbiological assessment domains.
Journal article. Patients with diabetic foot osteomyelitis.
Current guidelines endorse tailoring antimicrobial treatment based on resection margins without formal operationalization or prospective validation Resection margin assessment varies across surgical, histopathological, and microbiological domains and is often discordant Current recommendations are informed by limited trial data with uncertain ascertainment of residual infection
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should recognize that current guideline recommendations for margin-based treatment stratification lack standardized definitions and prospective evidence. Before routine implementation of this approach, standardized definitions and prospective validation studies are needed to improve reliability and complicatedness of treatment decisions.
This is a clinical perspective article critiquing current guideline recommendations for diabetic foot osteomyelitis that lack prospective validation and rely on poorly standardized constructs.
Clinicians should recognize that current guideline recommendations for margin-based treatment stratification lack standardized definitions and prospective evidence. Before routine implementation of this approach, standardized definitions and prospective validation studies are needed to improve reliability and complicatedness of treatment decisions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Updated guidelines endorse tailoring antimicrobial treatment for diabetic foot osteomyelitis (DFO) based on resection margins, representing a shift toward more individualized therapy. While conceptually appealing, this approach relies on a construct that remains ill-defined and inconsistently measured. Historically, infectious diseases management has emphasized source control without formal operationalization of resection margins. In DFO, the concept has evolved from descriptive assessments of residual infected bone to categorical designations of "positive" or "negative" margins, largely without prospective validation. Current recommendations are informed in part by limited trial data with uncertain ascertainment of residual infection. At the bedside, resection margin assessment varies across surgical, histopathological, and microbiological domains that are not interchangeable and often discordant, limiting reliability and complicating treatment decisions. Standardized definitions and prospective validation are needed before routine implementation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.